Growth factor delivery methods in the management of sports injuries: The state of play

British Journal of Sports Medicine

Volumn 42, Issue 5, 2008, Pages 314-320

  Creaney, Leon ^a   Hamilton, B ^b  

^a NORTHWICK PARK HOSPITAL   (United Kingdom)

^b ASPETAR ORTHOPAEDIC AND SPORTS MEDICINE HOSPITAL   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; DECORIN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; MATRIX METALLOPROTEINASE; NONSTEROID ANTIINFLAMMATORY AGENT; PLATELET DERIVED GROWTH FACTOR; RELAXIN; SCATTER FACTOR; SOMATOMEDIN C; SURAMIN; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

AUTOLOGOUS CONDITIONED SERUM; BLOOD AUTOTRANSFUSION; CARCINOGENESIS; CLINICAL TRIAL; DOPING; EPICONDYLITIS; FIBROSIS; HUMAN; INFECTION; KNEE LIGAMENT INJURY; MUSCLE INJURY; MYOFIBROSIS; NONHUMAN; PHYSIOTHERAPY; PROTEIN BLOOD LEVEL; REVIEW; SERUM; SPORT INJURY; TENDINITIS; TENDON INJURY; THROMBOCYTE RICH PLASMA; WOUND HEALING;

ANIMALS; ATHLETIC INJURIES; DOPING IN SPORTS; FIBROSIS; HUMANS; INJECTIONS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; WOUND HEALING;

EID: 43949141206     PISSN: 03063674     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjsm.2007.040071     Document Type: Review

References (55)

1. Kasemkijwattana C, Menetrey J, Bosch P, et al. Use of growth factors to improve muscle healing after strain injury. Clin Orth Rel Res 2000;370:272-85.
2. Reynolds JF, Noakes TD, Schwellnus MP, et al. Non-Steroidal anti-inflammatory drugs fail to enhance healing of acute hamstring injuries treated with physiotherapy. SA Med J 1995;85:517-22.
3. Cibulka MT, Rose SJ, Delitto A, et al. Hamstring muscle strain treated by mobilising the sacroiliac joint. Physical Ther 1986;66:1220-3.
4. Shen W, Yong L, Huard J, et al. NS-398, a cyclooxygenase-2-specific inhibitor, delays skeletal muscle healing by decreasing regeneration and promoting fibrosis. Am J Pathol 2005;167:1105-17.
5. Molloy T, Wang Y, Murrell AC. The roles of growth factors in tendon healing and ligament healing. Sports Med 2003;33: 381-94.
6. Marx RE, Garg AK. Dental and craniofacial applications of platelet-rich plasma. Ch 1. Berlin: Quintessence Publishing Co.
7. Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med 2006;34:1774-8.
8. Eppley BL, Woodell JE, Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg 2004;114:1502-8.
9. Schmidmaier G, Herrmann S, Green J, et al. Quantitative assessment of growth factors in reaming aspirate, iliac crest, and platelet preparation. Bone 2006;39:1156-63.
10. Anitua E, Sanchez M, Nurden AT, et al. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol 2006;24:227-34.
11. Baines E. Plasma jab lessens pain in tennis elbow. GP magazine 27 October, 2006:2.
12. Menetry J, Kasemkijwattana C, Day CS, et al. Growth factors improve muscle healing in vivo. J Bone Joint Surg[Br] 2000;82B:131-7.
13. Sanchez AR, Sheridan PJ, Kupp LI. Is platelet-rich plasma the perfect enhancement factor? A current review. Int J Oral Maxillofac Implants 2003;18:93-103.
14. Alvarez RH, Kantarjian HM, Cortes JE. Biology of platelet-derived growth factor and its involvement in disease. Mayo Clin Proc 2006;81:1241-57.
15. Kurtz C, Loebig TG, Anderson DD, et al. Insulin-like growth factor 1 accelerates functional recovery from Achilles tendon injury in a rat model. Am J Sports Med 1999;27:363-9.
16. Efthimiadou A, Asimakopoulos B, Nikolettos N, et al. Angiogenic effect of intramuscular administration of basic and acidic fibroblast growth factor on skeletal muscles and influence of exercise on muscle angiogenesis. Br J Sports Med 2006;40:35-9.
17. Hildebrand K, Woo S, Smith D, et al. The effect of platelet-derived growth factor-BB on healing of the rabbit medial collateral ligament. An in vivo study. Am J Sports Med 1998;26:549-54.
18. Letson AK, Dahners L. The effects of combinations of growth factors on ligament healing. Clin Orthop 1994;308:207-12.
19. Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surgery 2004;62:489-96.
20. Anitua E, Andia I, Ardanza B, et al. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 2004;91:4-15.
21. Sanchez M, Anitua E, Azofra J, et al. Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices. Am J Sports Med 2007;35:245-51.
22. Anitua E, Andia I, Sanchez M, et al. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J Orthop Res 2005;23:281-6.
23. Philippou A, Maridaki M, Halapas A, et al. The role of insulin-like growth factor 1 (IGF-1) in skeletal muscle physiology. In Vivo 2007;21:45-54.
24. Berg U, Bang P. Exercise and circulating insulin-like growth factor-1. Horm Res 2004;62(Suppl 1):50-8.
25. Frechette JP, Martineau I, Gagnon G. Platelet-rich plasmas: growth factor contents and roles in wound healing. J Dent Res 2005;84: 434-9.
26. Wright-Carpenter T, Klein P, Schaferhoff P, et al. Treatment of muscle injuries by local administration of autologous conditioned serum: a pilot study on sportsmen with muscle strains. Int J Sports Med 2004;25:588-93.
27. Connell DA, Ali KE, Ahmad M, et al. Ultrasound-guided autologous blood injection for tennis elbow. Skeletal Radiol 2006;35:371-7.
28. Edwards SG, Calandruccio JH. Autologous blood injections for refractory lateral epicondylitis. J Hand Surg (Am) 2003;28:272-8.
29. Wright-Carpenter T, Opolon P, Appell HJ, et al. Treatment of muscle injuries by local administration of autologous conditioned serum: animal experiments using a muscle contusion model. Int J Sports Med 2004;25:582-7.
30. Taylor MA, Norman TL, Clovis NB, et al. The response of rabbit patella tendons after autologous blood injection. Med Sci Sports Exerc 2002;34:70-3.
31. Chan Y, Yong L, Huard J, et al. The use of Suramin, an antifibrotic agent, to improve muscle recovery after strain injury. Am J Sports Med 2005;33:43-51.
32. Carda C, Mayordomo E, Enciso M, et al. Structural effects of the application of a preparation rich in growth factors on muscle healing following acute surgical lesion. Poster presentation at the 2nd International Conference on Regenerative Medicine 2005. http://www.regmed.org/2005
33. Aspenberg P, Virchenko O. Platelet concentrate injection improves Achilles tendon repair in rats. Acta Orthopaed Scand 2004;75:93-9.
34. Roy H, Bhardwaj S, Yla-Herttuala S. Biology of vascular endothelial growth factors. FEBS Letts 2006;580:2879-87.
35. Huard J, Yong L, Fu F. Muscle injuries and repair: current trends in research. J Bone Joint Surg 2002;84A:822-32.
36. Grazul-Bilska AT, Johnson ML, Bilski JJ, et al. Wound healing: the role of growth factors. Drugs of Today 2003;39:787- 800.
37. Musaro A. Growth factor enhancement of muscle regeneration: a central of IGF-1. Archives Italiennes de Biologie 2005;143:243-8.
38. Sanchez M, Azofra J, Anitua E, et al Use of a preparation rich in growth factors in the operative treatment of ruptured Achilles tendon. Poster Presentation at 2nd International Conference on Regenerative Medicine 2005. http://www.regmed.org/2005 (accessed 17 Mar 2008).
39. Sanchez M, Anitua E, Andia I. Application of autologous growth factors on skeletal muscle healing. Poster Presentation at 2nd International Conference on Regenerative Medicine 2005. http://regmed2005.abstract-management. de/overview/?ID=314 (accessed 17 Mar 2008).
40. Negishi S, Li Y, Usas A, et al. The effect of Relaxin treatment on skeletal muscle injuries. Am J Sports Med 2006;33:1816-24.
41. Suresh SP, Ali KE, Jones H, et al. Medial epicondylitis: is ultrasound guided autologous blood injection an effective treatment? Br J Sports Med 2006;40:935-9.
42. James SLJ, Ali K, Pocock C, et al. Ultrasound guided dry needling and autologous blood injection for patella tendinosis. Br J Sports Med 2007;41:518-21.
43. Meijer H, Reinecke J, Becker C, et al. The production of anti-inflammatory cytokines in the whole blood by physico-chemical induction. Inf Res 2003;52:404-7.
44. Shen W, Prisk V, Yong L, et al. Inhibited skeletal muscle healing in cyclooxygenase-2 gene-deficient mice: the role of PGE2 and PGF2alpha. J App Physiol 2006;101:1215-21.
45. Prisk V, Huard J. Muscle injures and repair: the role of prostaglandins and inflammation. Histol Histopathol 2003;18:1243- 56.
46. Keenan MA. Promising scientific areas and emerging technologies. Presentation to Musculoskeletal Research Conference, Bethesda, MD, January 2006.
47. Banfi G, Corsi MM, Volpi P. Could platelet rich plasma have effects on systemic circulating growth factors and cytokine release in orthopaedic applications? Br J Sports Med 2006;40:816.
48. Coghlan A. Rapid healing trick falls foul of anti-doping rules. New Scientist 14 May 2005.
49. World Anti-Doping Agency. http://www.wada-ama.org (accessed 17 Mar 2008).
50. Berg U, Gustafsson T, Bang P, et al. Local changes in the insulin-like growth factor system in human skeletal muscle assessed by microdialysis and arterio-venous differences technique. GH IGF Res 2006;16:217-23.
51. Juul A, Holm K, Kastrup KW, et al. Free insulin-like growth factor 1 serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency. J Clin Endo Met 1997;82:2497-502.
52. Mayo Reference Services. Communiqué 2006;31(3).
53. Laron Z, Klinger B. Effect of insulin-like growth factor-I treatment on serum androgens and testicular and penile size in males with Laron syndrome (primary growth hormone resistance) Eur J Endocrinol 1998;138:176-80.
54. Ljungqvist A, Schwellnus M, Cook J, et al. IOC Consensus Statement: Molecular basis of connective tissue and muscle injuries in sport, Feb 2007. http://www.olympic.org (accessed 17 Mar 2008).
55. 1. J Neuroimmunol 1996;70:37-44.